Skip to content

Feasibility of Home Based Transcutaneous Spinal Cord Stimulation for Persons With SCI

Feasibility of a Video Telehealth Model to Evaluate Home Use of Transcutaneous Spinal Cord Stimulation for Enhanced Upper Limb Function

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06140706
Enrollment
10
Registered
2023-11-20
Start date
2025-09-01
Completion date
2027-12-31
Last updated
2025-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tetraplegia

Keywords

paralysis, exercise, telemedicine, spinal cord stimulation, physical activity

Brief summary

The proposed study will focus on the feasibility of and effectiveness to a home-based program for persons with chronic SCI focused on upper limb training augmented with a transcutaneous neurostimulator supported via a video telehealth platform.

Detailed description

The overarching goal of this study is to train participants with tetraplegia and their companion to operate a non-invasive surface applied neurostimulation unit (ONWARD, ARCex) while performing a prescriptive functional task based upper extremity home program for 2 months. Participants will be supported with video-telehealth to assist with any difficulties that may arise and to progress their upper extremity home program. Evaluations will assess the feasibility of this video telehealth supported model as measured by the ease of use of the technology (QUEST 2.0, NASA-TLX) as well as participants ability to attend and complete all the training visits. Changes in upper extremity physical function will be measured using validated clinical tools (GRASSP, CUE-Q, DASH, COPM) as well as detailed evaluation of upper extremity muscle activation from surface EMG and strength measurements of pinch and grasp. The primary outcome measure of this study is feasibility, and the secondary outcome measure is to capture changes in upper extremity performance.

Interventions

Neurostimulation for upper extremity training, delivered through video telehealth, 8 weeks of home use for (i) feasibility and (ii) potential functional improvement.

Sponsors

ONWARD Medical, Inc.
CollaboratorINDUSTRY
VA Palo Alto Health Care System
Lead SponsorFED

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Veteran 2. Age 18-65 3. All gender, any ethnicity 4. Cervical Spinal Cord Injury C2-8 5. American Spinal Injury Association (ASIA) Impairment Scale (AIS) B, C or D 6. GRASSP-Prehension Score \>10 or GRASSP Strength Score \>30 7. Greater than 1 year post injury 8. Able to identify a companion to assist with neurostimulator setup in home environment. 9. Internet connection to support video telehealth connection 10. Willingness to travel to the VA Palo Alto Medical Center

Exclusion criteria

1. Cardiopulmonary disease or cardiac symptoms, 2. Autonomic dysreflexia that is uncontrolled or severe, 3. Implanted medical device(s), 4. Uncontrolled spasms that could limit participation in exercise training, 5. Skin breakdown or active pressure injury in areas of electrode placement. 6. Participants must not be engaged in any concurrent drug or device trial 7. Pregnant, are planning to become pregnant, or breastfeeding 8. The study is not deemed safe or appropriate in the opinion of the investigators

Design outcomes

Primary

MeasureTime frameDescription
NASA-TLX (NASA Task Load Index)At 8 weeks (after completion of home program)Measures subjective mental work load & physical effort
QUEST 2.0 (Quebec User Evaluation of Satisfaction with assistive Technology)At 8 weeks (after completion of home program)Measures usability of device (eg, adjustability, comfort, safety and effectiveness)

Secondary

MeasureTime frameDescription
GRASSP (The Graded Redefined Assessment of Strength Sensibility and Prehension)At entry (Baseline) and repeated at 8 weeks (after completion of home program)Measures upper limb sensation, strength, and prehension
CUE-Q (Capabilities of Upper Extremity Function)At entry (Baseline) and repeated at 8 weeks (after completion of home program)Measures functional limitation and difficulty in performing upper limb activities
DASH (Disabilities of the Arm, Shoulder, and Hand)At entry (Baseline) and repeated at 8 weeks (after completion of home program)Measures upper limb function during ADL tasks, work activities, recreational sports, and pain-related limitations
COPM (Canadian Occupational Performance Measure)At entry (Baseline) and repeated at 8 weeks (after completion of home program)Measures performance & satisfaction of self-identified activities in self-care, productivity and leisure

Countries

United States

Contacts

Primary ContactJeffrey Jaramillo, DPT
jeffrey.jaramillo@va.gov650-493-5000
Backup ContactJenny Kiratli, PhD
jenny.kiratli@va.gov650-493-5000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026